Malaria
📧 Sign up to get email alerts when something new happens for Malaria.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-03-17FDA Approved: CHLOROQUINE PHOSPHATE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for chloroquine phosphate by Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2022-03-14Clinical Trial Update: Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination [Phase 3]
Phase 3 trial evaluating mass drug administration of ivermectin and dihydroartemisinin-piperaquine as an additional intervention for malaria…
-
FDA approval · 2022-02-25FDA Approved: ARAKODA — Supplemental Application (60 Degrees Pharmaceuticals, INC.)
The FDA approved a supplemental application for ARAKODA (tafenoquine) by 60 Degrees Pharmaceuticals, expanding the medication’s labeling/ind…
-
CLINICAL_TRIALS trial_result · 2022-02-24Clinical Trial Update: Adjunctive Ivermectin Mass Drug Administration for Malaria Control [Phase 3]
Phase 3 clinical trial update on adjunctive ivermectin MDA for malaria control and related neglected tropical diseases.
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: A Challenge Study to Assess the Safety, Immunogenicity and Efficacy of a Malaria Vaccine Candidate [Phase 1, Phase 2]
Phase 1/2 trial update evaluating a malaria vaccine candidate for safety, immunogenicity, and efficacy has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-02-10FDA Approved: QUINIDINE SULFATE — Supplemental Application (EPIC PHARMA, LLC)
FDA approved a supplemental application for Quinidine Sulfate tablets from Epic Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: Safety and Efficacy of Recommended Antimalarial in the Democratic Republic of the Congo [Phase 4]
Phase 4 trial update assessing safety and efficacy of a recommended antimalarial in the Democratic Republic of the Congo has completed.
-
CLINICAL_TRIALS trial_result · 2022-01-28Clinical Trial Update: Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) [Phase 3]
Phase 3 trial update on seasonal malaria vaccination (RTS,S/AS01) and seasonal malaria chemoprevention (SP/AQ) completed with results posted…
-
CLINICAL_TRIALS trial_result · 2022-01-28Clinical Trial Update: Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Mali [Phase 1]
This Phase 1 trial assessed safety and immunogenicity of two malaria transmission-blocking vaccines, Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01,…
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria [Phase 3]
Phase 3 trial comparing pyronaridine artesunate to chloroquine in children and adults with acute vivax malaria; the study was terminated wit…
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: Human Mass Balance Study of Pyronaridine [Phase 1]
Phase 1 study evaluating human mass balance of pyronaridine in malaria patients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: Gametocytocidal and Transmission-blocking Efficacy of PQ in Combination With AL and TQ in Combination With SPAQ in Mali [Phase 2]
Phase 2 clinical trial evaluating gametocytocidal and transmission-blocking efficacy of PQ with AL and TQ with SPAQ in malaria patients in M…
-
FDA approval · 2022-01-14FDA Approved: SOVUNA — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved SOVUNA (hydroxychloroquine sulfate) under an original application by ANI Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2021-12-15Clinical Trial Update: Safety and Protective Efficacy of Pb(PfCS@UIS4) [Phase 1, Phase 2]
Phase 1/2 trial assessing safety and protective efficacy of Pb(PfCS@UIS4); results completed with posted results in 2021.
-
CLINICAL_TRIALS trial_result · 2021-12-13Clinical Trial Update: Study to Assess Safety, Tolerability and Phamacokinetics of KAE609 Administered Intravenously in Healthy Subjects [Phase 1]
Phase 1 trial assessing safety, tolerability, and pharmacokinetics of intravenous KAE609 in healthy subjects for malaria; study completed wi…
-
CLINICAL_TRIALS trial_result · 2021-12-09Clinical Trial Update: MMV390048 POC in Patients With P. Vivax and P. Falciparum Malaria [Phase 2]
Phase 2 trial update for MMV390048 in Plasmodium vivax and Plasmodium falciparum malaria; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2021-12-09Clinical Trial Update: Vectron T500 (Broflanilide 50WP) for IRS in Tanzania Tanzania [Phase 3]
Phase 3 clinical trial update for Vectron T500 (Broflanilide 50WP) investigating its use for indoor residual spraying against Falciparum mal…
-
CLINICAL_TRIALS trial_result · 2021-11-22Clinical Trial Update: Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients [Phase 3]
Phase 3 trial comparing pyronaridine-artesunate 3:1 granules to crushed Coartem tablets in pediatric Plasmodium falciparum malaria; study co…
-
CLINICAL_TRIALS trial_result · 2021-11-12Clinical Trial Update: Assessing a Risk Model for G6PD Deficiency [Phase 4]
Phase 4 trial assessing a risk model for glucose-6-phosphate dehydrogenase (G6PD) deficiency related to malaria; study terminated with resul…
-
FDA approval · 2021-10-25FDA Approved: ATOVAQUONE — Original Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved the original application for atovaquone, including the oral suspension, from PAI Holdings, LLC dba PAI Pharma, marking approval…
-
CLINICAL_TRIALS trial_result · 2021-10-13Clinical Trial Update: VAC 072-An Efficacy Study of R21/MM in Different Dose Schedules [Phase 1, Phase 2]
A Phase 1/2 trial evaluating different dose schedules of R21/MM for malaria has been completed.
-
CLINICAL_TRIALS trial_result · 2021-10-07Clinical Trial Update: Safety, Tolerability and Protective Efficacy of PfSPZ Vaccine in Gabonese Children [Phase 2]
Phase 2 trial update assessing safety, tolerability, and protective efficacy of the PfSPZ Vaccine in Gabonese children for malaria.
-
CLINICAL_TRIALS research · 2021-10-07Clinical Trial Update: Efficacy of Antimalarial Drugs Used for the Treatment of Uncomplicated Malaria, Plasmodium Falciparum, at the Agadez, Gaya and Tessaoua Sentinel Sites [Phase 4]
Phase 4 clinical trial update evaluating the efficacy of antimalarial drugs for uncomplicated Plasmodium falciparum malaria at sentinel site…
-
CLINICAL_TRIALS trial_result · 2021-09-20Clinical Trial Update: Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients [Phase 3]
Phase 3 trial comparing Pyronaridine Artesunate (3:1) to Coartem in Plasmodium falciparum malaria; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-20Clinical Trial Update: Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax Malaria [Phase 3]
Phase 3 trial update of Pyronaridine Artesunate (3:1) in children and adults with acute Plasmodium vivax malaria; study completed with resul…